Singapore markets closed
Straits Times Index
3,426.47 -3.98 (-0.12%) Nikkei
37,667.41 -202.10 (-0.53%) Hang Seng
17,021.31 +16.34 (+0.10%) FTSE 100
8,285.71 +99.36 (+1.21%) Bitcoin USD
68,217.89 +1,235.41 (+1.84%) CMC Crypto 200
1,380.37 +49.77 (+3.74%)
Moringa Acquisition Corp (MACA)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 11.70 |
| Open | 11.69 |
| Bid | 0.00 x 0 |
| Ask | 11.50 x 100 |
| Day's range | 11.69 - 11.69 |
| 52-week range | 10.63 - 12.59 |
| Volume | |
| Avg. volume | 304 |
| Market cap | 45.241M |
| Beta (5Y monthly) | 0.02 |
| PE ratio (TTM) | 32.47 |
| EPS (TTM) | 0.36 |
| Earnings date | 12 Aug 2024 - 16 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswireSilexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition Corp
Silexion’s first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors an oncogene believed to be a major driver of the cancer In combination with chemotherapy, Loder resulted in a median overall survival (OS) advantage of 9.3 months over chemotherapy alone (22.7 vs 13.4 months) Modi’in, Israel and New York, New York, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (Nasdaq: MACA) (“Mor
© 2024 Yahoo. All rights reserved.